Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors

NCT00253565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: capecitabine
DRUG: imatinib mesylate

Sponsor

Herbert Hurwitz

Collaborators

[object Object]